The companies are among the top ten drug manufacturers lobbying the White House and Congress, having spent upwards of $7 million (SFr7.05 million) combined during the first half of 2009 to influence policy.
Roche, Novartis and other groups lobbying Washington spent a total of nearly $400 million lobbying lawmakers on health care reform, President Barack Obama's biggest domestic priority. Congress is currently working on several bills that tackle the issue. More...
Don't miss:
- Olbermann and the "prostitutes" of health insurance...
- 45 million people uninsured in America?
- Novartis boss earned nearly 40 million dollars in 2008...
- Animal rights militants bomb Novartis chairman's home...
- How Big Pharma dopes and dupes...
- Harvard Medical School and Big Pharma...
No comments:
Post a Comment